Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
It is generally considered well-tolerated, however, there have been some reports of mild irritation at the injection site or allergic reactions
Elevated serum levels of interleukin-17A in children with autism
Key metabolic effects include: Enhanced lipolysis through activation of fat breakdown pathways independent of growth hormone receptors Suppressed lipogenesis reducing conversion of non-fat substrates into stored fat Increased fat oxidation and energy expenditure in multiple species models No adverse effects on insulin sensitivity or glucose metabolism, unlike full-length growth hormone Independence from IGF-1 Signaling A critical distinction of AOD-9604 is its lack of IGF-1 pathway activation: No measurable changes in serum IGF-1 levels in human clinical trials Absence of growth-promoting effects on tissues No impact on blood glucose regulation or insulin resistance Avoidance of typical growth hormone side effects including edema and tissue overgrowth Metabolic Pathway Modulation Research indicates AOD-9604 influences energy metabolism through multiple mechanisms: Increased whole-body fat oxidation rates in animal models Enhanced metabolic rate without stimulant-like effects Potential modulation of uncoupling proteins in adipose tissue Effects on lipid metabolism that persist beyond plasma clearance Critical Mechanistic Gap: Despite extensive research, the primary receptor target for AOD-9604 remains unidentified
Supports digestive and gut health
132,133,134 Canonical Wnt signalling acts indirectly on -catenin to enhance its stability, allowing it to translocate from the cell surface to the nucleus, thereby linking extracellular signalling to nuclear gene expression regulation through downstream transcriptional machinery (Fig
US$ 28.51
US$ 27.58
US$ 22.14
US$ 28.45
US$ 26.52
US$ 20.50
US$ 20.78
US$ 26.46
US$ 24.94